This shareable PDF can be hosted on any platform or network and is fully compliant with publisher copyright.
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
This page is a summary of: Characterization and cytocompatibility of a new injectable multiphasic bone substitute based on a combination of polysaccharide gel-coated OSPROLIFE®HA/TTCP granules and bone marrow concentrate, Journal of Biomedical Materials Research Part B Applied Biomaterials, May 2015, Wiley,
DOI: 10.1002/jbm.b.33441.
You can read the full text:
Be the first to contribute to this page
